About 30% of people with diabetes started on GLP-1’s stop taking this medication before completing a year of therapy.
According to ADA Standards, what results from sudden discontinuation of GLP-1s /GIP like semaglutide and tirzepatide?
- People maintain their weight loss for at least a year.
- People regain at least one-half of their weight loss within a year.
- People experience decreased nausea and less than 10% weight regain.
- People continue behaviors learned on medication with ongoing weight loss success.
Ignite your passion & prepare for Diabetes Certification!
Join our Expert Team at our dynamic Virtual DiabetesEd Training Conference April 16-18th, 2025
Gain fresh insights, practical tools, and a deeper understanding of the latest in person-centered diabetes care. Our expert team brings the ADA Standards of Care to life—covering medications, behavior change, technology, and more! If you’re preparing for the CDCES or BC-ADM exam, this conference—paired with free bonus courses—serves as the ideal study companion!
With interactive co-teaching, we keep sessions engaging, relevant, and fun. Let’s learn and grow together!
Our expert team transforms complex diabetes science into clear, practical insights—keeping it real, engaging, and fun! The faculty includes:
- Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES
- Coach Beverly Thomassian, RN, MPH, CDCES, BC-ADM
- Christine Craig, MS, RD, CDCES
- 3 Days: of critical information delivered by passionate speakers in an engaging and fun format!
- 11 Bonus Online Courses: As a course attendee, you automatically receive a bonus online course bundle of 11 online courses valued at over
![](/wp-content/uploads/2023/01/insta-png-v5.png")
